logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Genor Biopharma-B (02595.HK) repurchased 319,000 shares for HK$8.119 million on September 18.

date
18/09/2026
Zhito Finance APP News: GenFleet Therapeutics-B (02595.HK) announced that on September 18, 2026, the company repurchased 319,000 shares for HK$8.119 million.
Latest
1 m ago
TransThera-B (02617.HK): Jienertai (tinengotinib) included in the CSCO Guidelines for the Diagnosis and Treatment of Biliary Tract Malignancies (2026)
2 m ago
U.S. department store retailer Dillard's will move its U.S. stock exchange listing location to Texas.
4 m ago
Yili International (00585.HK): Tan Wenkang Appointed as Chairman of the Audit Committee
4 m ago
Titan Wind Energy (300129.SZ) plans to cooperate with professional institution Jinda Capital to jointly establish an investment fund.
7 m ago
Tiany Semiconductor (02658.HK) repurchased 5,600 shares for HK$214,700 on September 18.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.